← Return to Short acting Ocreotide
Discussion
Neuroendocrine Tumors (NETs) | Last Active: Sep 2 3:29pm | Replies (9)
Comment receiving replies
Replies to "Thank you for your quick response I took 3 infusions of Lanreotide in 2022 had to..."
Makes sense on why you want to try the short acting octreotide. I hope insurance covers it and it works well for you. If covered under the Medicare Part D plan, the good news is in 2025 there will be an out of pocket (copays) limit of $2000 for prescription meds. You are likely taking other meds that will be included in that limit. If home injection octreotide is not covered then unfortunately there wouldn’t be a limit. Blessings.